Evotec, Germany
Matthias Austen, Dr.
SVP Cell Therapy at Evotec
Research interests: PSC biology, process development for PSC-based cell therapy, pancreatic islet cell differentiation
STRATEGIES FOR THE DEVELOPMENT OF ALLOGENIC iPSC-DERIVED CELL THERAPIES
Thursday, July 11, 2024
8:15 AM – 9:45 AM CEST